chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Total body aches, chills, headache, fever, nausea, vomitting, sweating.  The vomitting started around 5pm the day after the injection.  I threw up every hour for the next 5 hours (not able to eat or drink water without it coming back up).  Prior to that I was just nauseous but could drink and eat a little.  I had to use a suppository at 9pm and at midnight I was still nauseous.  Was able to sleep but next morning head and neck were killing me.
Received flu vaccine. FLUZONE QUADRIVALENT 0.5 ml into (R) deltoid on11/11/15. Notified employee health of shoulder pain 11/23/15, stating it began slowly after vaccination received. States hard to move (R) arm or lift it all up. Cancelled scheduled doctor appt for 11/25/15, but went to ER 11/27/15.
shingles; death; Information has been received from a lawyer refers to an erderly male patient. The patient's medical history and concurrent conditions were not reported. In 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, unit, route of administration, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions, in medical office. Subsequently, the patient was treated by various healthcare providers at medical offices for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: shingles. The outcome of shingles was not reported. On 28-JUL-2018, the patient died (the cause of death and autopsy information were not reported). The reporter considered death and shingles to be related to zoster vaccine live (ZOSTAVAX).
Vasovagal syncope after Tdap and meningococcal vaccination. Occurred at approximately 1510. Pt was unconscious for 3-5 seconds, no fall or injury occurred as patient was sitting in chair. Pt was placed in supine position and ice bags were placed on neck and forehead. Patient fully recovered by 1517.
Pharmacist 38 1/2 weeks gestation broke out in shingles.  When symptoms became bothersome, employee went into labor and was in the hospital.  She received VALTREX.  Had previously had chicken pox ~age 6.  Employee was responsible for reconstituting ZOSTAVAX vaccine at clinic prior to and during pregnancy.
Initially I had arm soreness at the area of the shot.  Saturday evening following the vaccine I had pain in my left side of the neck.  Sunday the pain went from the left side of my neck down to the base of my ribs and then progressed to include the back and chest almost constantly instead of just on inhalation.  I went to the ER on Sunday evening, assuming very bad costochondritis; however, was diagnosed with multiple pulmonary embolisms in the left lung, areas of possible infarction, and pleurisy.  I had a CT scan at a Medical Center prior to receiving the Moderna vaccine for a suspected PE and it was negative.
Vomited after given vaccines and FLUMIST. Very sleepy, diaphoretic unable to stay awake. All vitals are normal. After 30 min. vomiting stopped. No treatment was given.
Pt noted right deltoid with redness, warmth and swelling and right cervical lymphadenopathy, 1 day after receiving TD, IM in right deltoid. Pt was advised to take Motrin or Tylenol and to ice the area. Pt returned to clinic on 3/13/03 for follow-up visit reporting symptoms had resolved.
03/31/00 Pt received TD on the upper left arm during routine physical. On the 3rd day post vax, this pt experienced redness and itchiness at the site. Subsequently a rash developed around the area. The pt had scratched the area and "maybe infected it" according to his grandmother. 04/03 pt returned to the clinic for follow up and informed the physician's assistant that he thought he may have had a reaction to the vax. Hydrocortisone cream was prescribed.
21JUL98 pt devel vesicular rash on rt arm painful & burning;seen by MD-dermatologist;Tzanck smear negative but felt this was herpes zoster;pt still having pain in arm c/w herpes zoster clinically;rash, lethargic, listless, fever;
02/21/2022 began to then you went to be tested 02/22/2022 COVID positive headache and sore thought and did not have breathing or trouble breathing and  need medication. Had antibody infusion 02/23/2022, had it done at the Hospital location. I am still having ongoing issue with chest pains when a deep breath is taken.
chills, fever (101.6), headache - 3 days lymph node swelling - 3 days fatigue - 3 days softball sized red rash, pain, itching - still ongoing
Narrative:  Covid pneumonia-SOB, remdesivir stopped, steroids, pt wanted rehab 88 years old, moderna x 2
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 4:05 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 58.60 for dose administered on 03-Apr-2021. No concomitant medications were reported. Batch number 030B21A underwent temperature excursion on 03-Apr-2021 with temperature 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported   This case was linked to MOD-2022-566976 (Patient Link).
Not able to get a good night's sleep since receiving the vaccine. I am still currently experiencing poor sleep quality. I am sleeping the sameduration as before the vaccine but my sleep quality has plummeted; wake up feeling as unrested as I did before sleeping. I wakeup unrested.untested. I go to bed each night by 10pm and wake up at 5am as I always have but have terriblerecovery.; Severe fatigue after the 2nd dose; Achy joints for approximately 24hrs; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo0170), via an unspecified route of administration in the left arm on 26Apr2021 at 17:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient did not have any allergies to medications, food or other products. Concomitant medications included olmesartan and amlodipine (AMLODIPINE;OLMESARTAN)) 40mg/5mg, vitamin d nos (MANUFACTURER UNKNOWN) and magnesium sulfate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo0151), via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 17:00, after the second dose, the patient experienced sever fatigue and achy joints for approximately 24hrs. On 27Apr2021 at 22:00, the patient was not able to get a good night's sleep since receiving the vaccine. The patient was currently experiencing poor sleep quality. The patient was sleeping the same duration as before the vaccine but his sleep quality has plummeted and he woke up feeling as unrested as he did before sleeping. The patient woke up unrested. The patient go to bed each night by 22:00 and woke up at 05:00 as always but had terrible recovery. The patient had made no changes in his sleep environment. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as the result of poor sleep quality and wake up unrested which included OTC sleep aid but had not provided any favorable results. Therapeutic measures were not taken for the events severe fatigue and achy joints. On 11May2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events severe fatigue and achy joints were recovered on 27Apr2021 at 17:00. The clinical outcome of the events poor sleep quality and wake up unrested were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
May 20 2021 12:20pm second dose of covid vaccine received  2:00pm headache and mild chills started. Took tylenol 1tab & slept 04:00pm diarrhea started 3-4x soft to watery stool 21:00pm itchiness started at the chest, shoulder, abdomen, back and arms May 21 2021 08:00 chills started 10:30 temp 38.5C with severe headache took tylenol  12:00 still with itchiness on both arms 15:00 took another dose of tylenol 17:00 mild rashes noted on both arms and chest 19: 00 Still continue to observe
Almost exactly 24 hrs following the Hep B shot, the following symptoms occured: 1pm -  severe headache lasting 4 hrs. took ibuprofen 200mg. 3pm - 430pm - projectile vomiting. 430pm  - swelling of both sinuses and throat causing breathing difficulty. Took sudafed. All symptoms subsided by 8pm, with the exception of the minor swollen throat remaining.
Headache, Myalgia, soreness of site, HA and fatigue for 72 hrs first dose. second dose- soreness headache body aches for 72 hrs Narrative:  Other Relevant History:
Swelling of (R) arm pit - size of goose egg (noted am 6/21/12). Swelling of (R) deltoid at injection site (noted am 6/20/12). Fever 101 degrees F (noted 6/20/12 pm).
soreness of arm; he got flushed; rapid heart beat; high blood pressure; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included myasthenia gravis (since Dec 2014 treated with plasmapheresis) and erectile dysfunction. Concomitant products included nitric oxide, Rockstar Energy Drink, prednisone and azathioprine.   On 26th February 2020, the patient received the 1st dose of Shingrix (intramuscular). On 26th February 2020, less than a day after receiving Shingrix, the patient experienced injection site pain, flushing, heartbeats increased and blood pressure high. On 26th February 2020, the outcome of the flushing and heartbeats increased were recovered/resolved. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the blood pressure high was recovered/resolved.   It was unknown if the reporter considered the injection site pain, flushing, heartbeats increased and blood pressure high to be related to Shingrix.  Additional details were provided as follows: The patient experienced a little soreness of his arm (at injection site). At the time of reporting it was still a little sore but it was resolving. The patient had used those products before without side effects however when he used them day before reporting and then proceeded with his (sexual) activity he got flushed and had to sit down and stop. The patient was having a rapid heartbeat and high blood pressure.  The patient states that his blood pressure was usually around 100 by 55 and it was about 140 by 80. The patient states that his heart rate was normally 60 to 65 and it was 80.   The heart rate took longer to go down but it was below 80 today.  It was states that he has never had an episode like this before. He was not sure if it was related to the Shingrix or not but it was the only thing different that he can think of. Did not consent to follow-up.
Janssen COVID-19 Vaccine EUA  Feeling very tired, then muscle aches, chills, low-grade fever and headache.  Symptoms were quite intense.  Symptoms improved when Tylenol was taken.  Symptoms began approximately 6 hours after vaccination and ended about 24 hours after vaccination.
It wasn't really an adverse reaction to the shot but I awoke on 9/18 with symptoms of a head cold. After not improving my employer requested I be tested for COVID and I was at Benefis on September 21st. I was COVID positive. I received an infusion of antibodies on September 22, 2021 and started to improve. I returned to work on September 29th. Still tired and congested.
AFTER RECEIVING THE INJECTION HE BECAME VERY DIAPHORETIC. ON SITE EMS RESPONDED. VITALS BELOW. HE RECOVERED AND WAS RELEASED TO HOME
30 year old healthy male with no preexisting conditions who developed morbiliform rash on the trunk, upper back, and inguinal creases bilaterally, 36 hours after 2nd dose of Pfizer Vaccine. The rash spared the mucosal membranes, face, and extremities.  The rash was not itchy or painful. No co current fever or other systemic symptoms. Patient does not have history or drug, vaccine, or food allergies. In particular, no known allergy to polyethylene glycol. Patient does not take any medications daily, though took acetaminophen and Ibuprofen at the time of vaccine and then for the next 24 hours.
Received phone call from Ellisville Clinic regarding child presented with pain in teeth and jaw dx with Bells Palsy.
The day after the vaccine she experienced arm immobility, difficulty breathing, and urticaria spreading across her entire upper arm.
Patient stated she had severe diarrhea and vomiting approximately 2 hours after she received the vaccine. She went to a walk-in clinic and they gave her benedryl 12.5mg and Zofran 4mg. She was not feeling better, and later went to the ER where she received 1000ml of Normal Saline, Tylenol 650mg and Zofran 4mg
Information has been received from a health professional concerning a 5 year old white male who on 29-JUN-2001 was vaccinated in the left thigh with a first dose of Varivax (lot # 638566/1886K). on 17-MAR-2006 the patient was seen with a rash on the trunk. He was seen again on 20-MAR-2006 and had <20 lesions on the trunk that were consistent with varicella. No labs or diagnostic tests were performed. Additional information has been requested.
received only the MenA component; received only the MenA component; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA762A, expiry date 30th November 2022) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 16-NOV-2022 Reporter's Comments: A nurse reported that a male patient received only the Men A component of Menveo. The consented to follow up. Additional Supportive Information: the patient received only the Men A component of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine.; Sender's Comments:  US-GSK-US2022170326:same reporter
out of the 42 day interval range; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (out of the 42 day interval range) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (out of the 42 day interval range). At the time of the report, PRODUCT DOSE OMISSION ISSUE (out of the 42 day interval range) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient was currently 48 days post first dose. No concomitant medications provided. No treatment information provided.
he has Hashimoto's Disease and is immunocompromised; he has Hashimoto's Disease and is immunocompromised; Approximately 12 hours after receiving the first dose he began to have pain in his right eye only.; swelling of the soft tissue behind the eye and believes it is from the vaccine; This is a spontaneous report from a contactable consumer. A 55-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on an unspecified date as single dose for Covid-19 immunisation. Medical history and concomitant medications were not reported. Approximately 12 hours after receiving the first dose, the patient began to have pain in his right eye only.  He stated that he couldn't touch it, it felt like "my eye ball was going to explode out of my eye socket."  The pain continued for the next two days and is still there a bit now.  He saw his eye doctor last week and she saw swelling of the soft tissue behind the eye and believes it is from the vaccine. Also, on an unspecified date, the patient experienced Hashimoto's disease and is immunocompromised. The outcome of the events eye pain was not recovered. The outcome of other events was unknown.   Information on the lot/batch number has been requested.
The next day after receiving the vaccine I started feel the urge to urinate more frequently, and  pressure in my bladder. I went into the urgent care clinic 3 days later and they checked my urine to see if there was any infection. I was diagnosed with a urine infection and was given antibiotics. My symptoms lasted about 7-10 days.
Covid Arm - ichy- swelling- like a bee sting - large welt ring around injection site
headache; not eating; This is a spontaneous report from a contactable consumer (patient's wife). An 81-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 27Jan2021 at a single dose for COVID-19 immunization. Medical history included headache on 26Jan2021. There were no concomitant medications. The reporter stated that her husband (patient) received the first dose of the vaccine about two and one-half to three weeks ago and he had some aches and pain but it was not that bad. She reported that a day or two after the first dose he was achy and didn't feel like himself. Then on 26Jan2021, he got a major headache; he would sleep and wake up and sleep again trying to get rid of the headache. She gave him paracetamol (TYLENOL) 650 mg one by mouth and it didn't help. He got the second dose on 27Jan2021 between 07:00 and 09:00AM she was unsure of the arm. He came home and is sleeping now and had a headache on 27Jan2021. She was asking what can she give him for the headache. She also stated that he also was not eating on an unspecified date in Jan2021. She wanted more information on what to do for him. The events did not require a visit to the physician or ER. The outcome of the event headache was not recovered while the outcome of the event not eating was unknown.   Information about lot/batch number has been requested.
pt cried w/o stopping for more than 3 hrs p/DTP & kept screaming & being uncomfortable for 3 days; some local swelling; no fever;
6-2-09 Rcvd  MMR SubQ @ Health Dept.  6-11-09 Pt. returned to HD.  Exhibits approx 10 mm by 15 mm reddened & inflamed area upper outer aspect of Left ARM. 2nd smaller reddened area 5mm by 5mm in same arm.   Area itches & has some discomfort. Some discomfort in left axillary region as well.  6-11-09 visit to ER.  Dr states "allergic reaction to vaccine".  6/29/09 Medical records received DOS 8/07/08 to 4/08/09 Assessment: Cephalgia and Syncope. Patient presents with abdominal and pelvic pain. Menorrhagia. Later "passed out/blacked" out while driving. Plantar warts - cryosurgery, electrosurgery. Syncope, cough, cephalgia, emesis, fever. Nasal congestion and sinus pain. Serous effusion - ears. URI.  HPV Dose #1 - 4/11/08, HPV Dose #2 - 6/13/08, HPV Dose #3 - 1/9/09
Headache, Myalgia, Arthralgia, ErythemaMultiform, fatigue, arm soreness Narrative: Redness and pain at injection site, myalgia, arthralgia, headache, fatigue;
Pt recvd 2 doses of Engerix-B 6JUN92 & 6JUL92 & 2 days p/2nd dose exp a rash, nausea & vomiting; reporter indicated that the event was immediately life threatening; prescribed DPH;
Recurrent nausea, vomiting, diarrhea x 7 days. Instructed pt to increase fluids, given prescription for LOMOTIL and PHENERGAN for diarrhea & nausea. (Adverse reaction to Typhoid (oral) vaccine).
Less than time minutes blurvision,lightheadness,headache,4 hours later nose swallen at bridge with two big hives on both sides.Next morning severe cramp on right leg( Thursday). Friday morning severe pain in upper thigh couldn't work on it,called care source nurse 24/7 number. Called primary Dr. to report  what effects I was concerned with. Following Dr.s advice.Today April 12th,2021 pain persists in right thigh
Generalized hives - red welts - legs, buttocks, thighs, shoulders.
Syncope, Vomiting, flushing/sweating.  BP 122/47, HR 51, RR 16 -- > 125/71, 54, 16.  Pt fell to the floor but recovered after resting.  Pt stable and released from the vaccination site.
Systemic: Stroke-Severe, Additional Details: called patient to see if wanted 2nd dose. son answered. Patient had massive stroke 3 hours after vaccine administration. Still currently hospitalized in ICU.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-APR-2016 the patient was inadvertently vaccinated with expired dose of RECOMBIVAX HB (lot # J007946, expiry date: 24-MAR-2016). No adverse effect was reported. Additional information has been requested.